StonvexLoading…
StonvexCore line items from CIFR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $223.94M | $151.27M | $126.84M | $3.04M |
Operating Income | $-421.56M | $-43.70M | $-20.11M | $-37.42M |
Net Income | $-822.24M | $-44.63M | $-25.78M | $-39.05M |
EPS (Diluted) | $-2.15 | $-0.14 | $-0.10 | $-0.16 |
Total Assets | $4.29B | $855.45M | $566.14M | $418.46M |
Total Liabilities | $3.46B | $173.49M | $74.80M | $75.57M |
Cash & Equivalents | $628.26M | $5.58M | $74.18M | $11.93M |
Free Cash Flow OCF − CapEx | $-695.86M | $-227.01M | $-114.72M | $-60.13M |
Shares Outstanding | 404.96M | 350.78M | 290.96M | 247.55M |